Influence of Different Aromatic Hydrophobic Residues on the Antimicrobial Activity and Membrane Selectivity of BRBR-NH2 Tetrapeptide.

The ultrashort linear antimicrobial tetrapeptide BRBR-NH2 with an unnatural residue biphenylalanine (B) has potent and rapid antimethicillin-resistant Staphylococcus aureus (MRSA) activity but lacks hemolytic activity. The anti-MRSA activity of BRBR-NH2 is 8-fold more potent than that of WRWR-NH2 and 16-fold more potent than that of FRFR-NH2. However, how to influence their antimicrobial activities and mechanisms through the substitution of different aromatic hydrophobic residues is still unclear. In this work, to study the effects of varying hydrophobic interactions and membrane selectivities of BRBR-NH2, we performed multiple long-time (1000 ns) molecular dynamics (MD) simulations to investigate the interactions of a red blood cell (RBC) membrane and a Gram-positive bacterial cell membrane with three different tetrapeptides (BRBR-NH2, WRWR-NH2, and FRFR-NH2) under different ratios of peptides and lipids and also explored the changes in the membrane and structural characteristics of peptides. The binding energy results show that BRBR-NH2 interacts weakly with the RBC membrane, while not all BRBR-NH2 can be adsorbed to the RBC membrane surface. The MD simulation results produced significant local membrane thinning of multiBRBR-NH2 peptides in the Gram-positive bacterial cell membrane. An in-depth analysis of structural features and peptide-membrane interactions suggests that the aggregation of BRBR-NH2 on the membrane surface plays a crucial role in the destruction of the cell membrane. Taken together with the observed local membrane thinning, the in-depth analysis demonstrated that the interactions between the lipid bilayer and the BRBR-NH2 aggregation surface result in a local disturbance of the membrane structure. It can be concluded that the high anti-MRSA activity of BRBR-NH2 is attributed to the aggregation of BRBR-NH2 on the membrane surface. On the other hand, WRWR-NH2 and FRFR-NH2 peptides tend to bind with the membrane surface in a monomeric form and cover the membrane surface in a carpet-like manner. Therefore, these results provide an advanced microscopic understanding of how hydrophobic interactions or hydrophobic residues affect the antimicrobial activity and mechanism of antimicrobial peptides (AMPs).

[1]  Gregory A. Caputo,et al.  Investigation of the role of aromatic residues in the antimicrobial peptide BuCATHL4B. , 2020, Protein and peptide letters.

[2]  H. Kwok,et al.  Enhanced Antimicrobial Activity of N-Terminal Derivatives of a Novel Brevinin-1 Peptide from The Skin Secretion of Odorrana schmackeri , 2020, Toxins.

[3]  Guangshun Wang,et al.  Two distinct amphipathic peptide antibiotics with systemic efficacy , 2020, Proceedings of the National Academy of Sciences.

[4]  Amy K. Cain,et al.  An amphipathic peptide with antibiotic activity against multidrug-resistant Gram-negative bacteria , 2020, Nature Communications.

[5]  Yaoqi Zhou,et al.  Interplay of hydrophobic and hydrophilic interactions in sequence-dependent cell penetration of spontaneous membrane-translocating peptides revealed by bias-exchange metadynamics simulations. , 2020, Biochimica et biophysica acta. Biomembranes.

[6]  Blagojce Jovcevski,et al.  Short Photoswitchable Antibacterial Peptides. , 2020, ChemMedChem.

[7]  A. Duilio,et al.  Antimicrobial and Antibiofilm Peptides , 2020, Biomolecules.

[8]  Kelly M. Schultz,et al.  Nine-residue peptide self-assembles in the presence of silver to produce a self-healing, cytocompatible, antimicrobial hydrogel. , 2020, ACS applied materials & interfaces.

[9]  P. Sharma,et al.  Mini Review on Antimicrobial Peptides, Sources, Mechanism and Recent Applications , 2019, Protein and peptide letters.

[10]  S. Straus,et al.  Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions , 2019, Front. Microbiol..

[11]  H. Kwok,et al.  In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide , 2019, Molecular therapy oncolytics.

[12]  Majid Jafari,et al.  Molecular Basis for Membrane Selectivity of Antimicrobial Peptide Pleurocidin in the Presence of Different Eukaryotic and Prokaryotic Model Membranes , 2019, J. Chem. Inf. Model..

[13]  Martin Fechner,et al.  More bang for your buck: Improved use of GPU nodes for GROMACS 2018 , 2019, J. Comput. Chem..

[14]  Łukasz Nierzwicki,et al.  Are the short cationic lipopeptides bacterial membrane disruptors? Structure-Activity Relationship and molecular dynamic evaluation. , 2019, Biochimica et biophysica acta. Biomembranes.

[15]  Jagannath Mondal,et al.  A brief appraisal of computational modeling of antimicrobial peptides’ activity , 2018, Drug development research.

[16]  M. Jafari,et al.  Molecular insights into the interactions of GF‐17 with the gram‐negative and gram‐positive bacterial lipid bilayers , 2018, Journal of cellular biochemistry.

[17]  R. Mirnejad,et al.  Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria. , 2018, Microbial drug resistance.

[18]  C. Verma,et al.  Elucidating the bactericidal mechanism of action of the linear antimicrobial tetrapeptide BRBR-NH2. , 2018, Biochimica et biophysica acta. Biomembranes.

[19]  H. Vogel,et al.  Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues , 2018, Biomolecules.

[20]  Yaoqi Zhou,et al.  Molecular Dynamics Simulations of Human Antimicrobial Peptide LL-37 in Model POPC and POPG Lipid Bilayers , 2018, International journal of molecular sciences.

[21]  T. Ulmer,et al.  Membrane Anchoring of α-Helical Proteins: Role of Tryptophan. , 2018, The journal of physical chemistry. B.

[22]  R. Hoffmann,et al.  Antimicrobial and Antibiofilm Activity of UP-5, an Ultrashort Antimicrobial Peptide Designed Using Only Arginine and Biphenylalanine , 2018, Pharmaceuticals.

[23]  A. Saraswati,et al.  Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance. , 2017, Current medicinal chemistry.

[24]  B. Cornell,et al.  Phenylalanine residues act as membrane anchors in the antimicrobial action of Aurein 1.2. , 2017, Biointerphases.

[25]  E. Yun,et al.  A novel role for earthworm peptide Lumbricusin as a regulator of neuroinflammation. , 2017, Biochemical and biophysical research communications.

[26]  W. Wimley,et al.  Spontaneous Membrane Translocating Peptides: The Role of Leucine-Arginine Consensus Motifs. , 2017, Biophysical journal.

[27]  A. Sunda-Meya,et al.  Chain length effect on the structure and stability of antimicrobial peptides of the (RW)n series. , 2017, Biophysical chemistry.

[28]  J. Ulmschneider.  Charged Antimicrobial Peptides Can Translocate across Membranes without Forming Channel-like Pores. , 2017, Biophysical journal.

[29]  Zahra Razaghi Moghadam Kashani,et al.  Identification of the Crucial Residues in the Early Insertion of Pardaxin into Different Phospholipid Bilayers , 2017, J. Chem. Inf. Model..

[30]  S. Gorr,et al.  Antimicrobial Peptides: Mechanisms of Action and Resistance , 2017, Journal of dental research.

[31]  R. Fu,et al.  Simulations of Membrane-Disrupting Peptides II: AMP Piscidin 1 Favors Surface Defects over Pores. , 2016, Biophysical journal.

[32]  R. Pastor,et al.  Simulations of Membrane-Disrupting Peptides I: Alamethicin Pore Stability and Spontaneous Insertion. , 2016, Biophysical journal.

[33]  N. Malanovic,et al.  Antimicrobial Peptides Targeting Gram-Positive Bacteria , 2016, Pharmaceuticals.

[34]  M. Aguilar,et al.  Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure. , 2015, Current topics in medicinal chemistry.

[35]  Qiu Ying Lau,et al.  Discovery of an ultra-short linear antibacterial tetrapeptide with anti-MRSA activity from a structure-activity relationship study. , 2015, European journal of medicinal chemistry.

[36]  Alexander D. MacKerell,et al.  CHARMM-GUI Input Generator for NAMD, GROMACS, AMBER, OpenMM, and CHARMM/OpenMM Simulations Using the CHARMM36 Additive Force Field , 2015, Journal of chemical theory and computation.

[37]  Martin Fechner,et al.  Best bang for your buck: GPU nodes for GROMACS biomolecular simulations , 2015, J. Comput. Chem..

[38]  B. Bechinger.  The SMART model: Soft Membranes Adapt and Respond, also Transiently, in the presence of antimicrobial peptides , 2015, Journal of peptide science : an official publication of the European Peptide Society.

[39]  Sunhwan Jo,et al.  CHARMM‐GUI Membrane Builder toward realistic biological membrane simulations , 2014, J. Comput. Chem..

[40]  Rajendra Kumar,et al.  g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..

[41]  H. Griesser,et al.  Guanylated polymethacrylates: a class of potent antimicrobial polymers with low hemolytic activity. , 2013, Biomacromolecules.

[42]  Kyung S. Lee,et al.  Non hemolytic short peptidomimetics as a new class of potent and broad-spectrum antimicrobial agents. , 2013, Bioorganic & medicinal chemistry letters.

[43]  D. Nolde,et al.  Lipid-II forms potential “landing terrain” for lantibiotics in simulated bacterial membrane , 2013, Scientific Reports.

[44]  C. Verma,et al.  Molecular simulations suggest how a branched antimicrobial peptide perturbs a bacterial membrane and enhances permeability. , 2013, Biochimica et biophysica acta.

[45]  Alexander D. MacKerell,et al.  Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. , 2012, Journal of chemical theory and computation.

[46]  Taehoon Kim,et al.  CHARMM‐GUI: A web‐based graphical user interface for CHARMM , 2008, J. Comput. Chem..

[47]  H. Vogel,et al.  Structure-function analysis of tritrpticin analogs: potential relationships between antimicrobial activities, model membrane interactions, and their micelle-bound NMR structures. , 2006, Biophysical journal.

[48]  John P. Overington,et al.  How many drug targets are there? , 2006, Nature Reviews Drug Discovery.

[49]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[50]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[51]  S. Nosé.  A molecular dynamics method for simulations in the canonical ensemble , 1984 .

[52]  M. Parrinello,et al.  Polymorphic transitions in single crystals: A new molecular dynamics method , 1981 .

[53]  M. Bagheri,et al.  Molecular Dynamics Simulation and Analysis of the Antimicrobial Peptide-Lipid Bilayer Interactions. , 2017, Methods in molecular biology.

[54]  Yoonkyung Park,et al.  The therapeutic applications of antimicrobial peptides (AMPs): a patent review , 2017, Journal of Microbiology.

[55]  W. Dowhan,et al.  Molecular basis for membrane phospholipid diversity: why are there so many lipids? , 1997, Annual review of biochemistry.